Bioavailability & Bioequivalence Studies

Bioavailability means the rate and extent to which the active drug substance or therapeutic moiety is absorbed from a pharmaceutical form and becomes available at the site of action. For drugs intended to exhibit a systemic therapeutic effect, bioavailability can be more simply understood as the rate and extent to which a substance or its therapeutic moiety is delivered from a pharmaceutical form into the general circulation. Bioequivalence focus on the release of a drug substance from a drug product and subsequent absorption into systemic circulation. Bioequivalence studies are a surrogate marker for clinical effectiveness and safety data as it would not normally be practical to repeat clinical studies for generic products.

  • Invitro bioequivalence
  • Bioavailability metrics
  • Waiver of invivo bioavailability
  • Bioequivalence study protocols
  • Genetic phenotyping
  • Bioequivalence study design

 

    Related Conference of Bioavailability & Bioequivalence Studies

    December 02-03, 2020

    2nd International Conference on Bio-Pharmaceuticals

    Auckland, Newzealand
    December 07-08, 2020

    International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    December 16-16, 2020

    21st World Conference on Pharmaceutical Chemistry and Drug Design

    Singapore City, Singapore
    December 16-16, 2020

    22nd World Congress on Pharmacology, Nursing and Healthcare

    Algeria, Algeria
    January 22-23, 2021

    1 st Global Summit on Generic Drugs and Quality Control

    Prague, Czech Republic
    January 22-23, 2021

    1 st World Congress on Rare Diseases & Orphan Drugs

    Prague, Czech Republic
    February 26-27, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    March 10-11, 2021

    6th Pharmaceutical Chemistry Conference

    Paris, France
    March 15-16, 2021

    30th World Conference on Clinical Pediatrics

    Dubai, UAE
    March 16-17, 2021

    14th Global Pharmacovigilance And Clinical Trials Summit

    Albufeira, Portugal
    April 11-12, 2021

    2 nd World Pharma Expo

    Tokyo, Japan
    April 12-13, 2021

    2nd International Conference on Biosimilars & Pharmaceuticals

    Auckland, Newzealand
    April 28-29, 2021

    31st Annual European Pharma Congress

    London, UK
    April 28-29, 2021

    14th European Biosimilars Congress

    London, UK
    May 10-11, 2021

    20th Annual Meet on Pharmaceutical Sciences

    Yokohama, Japan
    May 17-18, 2021

    8th European Biopharma Congress

    Prague, Czech Republic
    May 19-20, 2021

    36th World Pharmacology and Therapeutics Forum

    Singapore, Singapore
    June 07-08, 2021

    2rd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    July 10-11, 2021

    2 nd Pharma Expo China

    Tokyo, Japan
    August 16-17, 2021

    Global summit on Cosmetic & Reconstructive Surgery

    Tokyo, Japan
    August 16-17, 2021

    34rd World Congress on Pharmacology

    London, UK
    October 29-30, 2021

    14th World Drug Delivery Summit

    Vancouver, Canada
    October 29-30, 2021

    12th Annual Biomarkers and Clinical Research Congress

    Vancouver, Canada

    Bioavailability & Bioequivalence Studies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in